Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of KPC Production and High-Level Meropenem Resistance on All-Cause Mortality of Ventilator-Associated Pneumonia in Association with Klebsiella pneumoniae.
Rivera-Espinar F, Machuca I, Tejero R, Rodríguez J, Mula A, Marfil E, Cano Á, Gutiérrez-Gutiérrez B, Rodríguez M, Pozo JC, De la Fuente C, Rodriguez-Baño J, Martínez-Martínez L, León R, Torre-Cisneros J. Rivera-Espinar F, et al. Among authors: pozo jc. Antimicrob Agents Chemother. 2020 May 21;64(6):e02164-19. doi: 10.1128/AAC.02164-19. Print 2020 May 21. Antimicrob Agents Chemother. 2020. PMID: 32205347 Free PMC article.
Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.
Fortún J, Muriel A, Martín-Dávila P, Montejo M, Len O, Torre-Cisneros J, Carratalá J, Muñoz P, Fariñas C, Moreno A, Fresco G, Goikoetxea J, Gavaldá J, Pozo JC, Bodro M, Vena A, Casafont F, Cervera C, Silva JT, Aguado JM; Grupo de Estudio de Infección en Pacientes Trasplantados-Grupo de Estudio de Micología Médica (Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica), and Red Española de Investigación en Patología Infecciosa. Fortún J, et al. Among authors: pozo jc. Liver Transpl. 2016 Apr;22(4):427-35. doi: 10.1002/lt.24391. Liver Transpl. 2016. PMID: 26709146 Free article.
Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms.
Temkin E, Torre-Cisneros J, Beovic B, Benito N, Giannella M, Gilarranz R, Jeremiah C, Loeches B, Machuca I, Jiménez-Martín MJ, Martínez JA, Mora-Rillo M, Navas E, Osthoff M, Pozo JC, Ramos Ramos JC, Rodriguez M, Sánchez-García M, Viale P, Wolff M, Carmeli Y. Temkin E, et al. Among authors: pozo jc. Antimicrob Agents Chemother. 2017 Jan 24;61(2):e01964-16. doi: 10.1128/AAC.01964-16. Print 2017 Feb. Antimicrob Agents Chemother. 2017. PMID: 27895014 Free PMC article.
Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
Rodríguez A, Díaz E, Martín-Loeches I, Sandiumenge A, Canadell L, Díaz JJ, Figueira JC, Marques A, Alvarez-Lerma F, Vallés J, Baladín B, García-López F, Suberviola B, Zaragoza R, Trefler S, Bonastre J, Blanquer J, Rello J; H1N1 SEMICYUC Working Group. Rodríguez A, et al. J Antimicrob Chemother. 2011 May;66(5):1140-9. doi: 10.1093/jac/dkq511. Epub 2011 Jan 7. J Antimicrob Chemother. 2011. PMID: 21385717
Impact of obesity in patients infected with 2009 influenza A(H1N1).
Díaz E, Rodríguez A, Martin-Loeches I, Lorente L, Del Mar Martín M, Pozo JC, Montejo JC, Estella A, Arenzana Á, Rello J; H1N1 SEMICYUC Working Group. Díaz E, et al. Among authors: pozo jc. Chest. 2011 Feb;139(2):382-386. doi: 10.1378/chest.10-1160. Epub 2010 Aug 5. Chest. 2011. PMID: 20688928
Early non-invasive ventilation treatment for severe influenza pneumonia.
Masclans JR, Pérez M, Almirall J, Lorente L, Marqués A, Socias L, Vidaur L, Rello J; H1N1 GTEI/SEMICYUC Investigators. Masclans JR, et al. Clin Microbiol Infect. 2013 Mar;19(3):249-56. doi: 10.1111/j.1469-0691.2012.03797.x. Epub 2012 Mar 8. Clin Microbiol Infect. 2013. PMID: 22404211 Free PMC article.
Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort.
Ceccato A, Forne C, Bos LD, Camprubí-Rimblas M, Areny-Balagueró A, Campaña-Duel E, Quero S, Diaz E, Roca O, De Gonzalo-Calvo D, Fernández-Barat L, Motos A, Ferrer R, Riera J, Lorente JA, Peñuelas O, Menendez R, Amaya-Villar R, Añón JM, Balan-Mariño A, Barberà C, Barberán J, Blandino-Ortiz A, Boado MV, Bustamante-Munguira E, Caballero J, Carbajales C, Carbonell N, Catalán-González M, Franco N, Galbán C, Gumucio-Sanguino VD, de la Torre MDC, Estella Á, Gallego E, García-Garmendia JL, Garnacho-Montero J, Gómez JM, Huerta A, Jorge-García RN, Loza-Vázquez A, Marin-Corral J, Martínez de la Gándara A, Martin-Delgado MC, Martínez-Varela I, Messa JL, Muñiz-Albaiceta G, Nieto MT, Novo MA, Peñasco Y, Pozo-Laderas JC, Pérez-García F, Ricart P, Roche-Campo F, Rodríguez A, Sagredo V, Sánchez-Miralles A, Sancho-Chinesta S, Socias L, Solé-Violan J, Suarez-Sipmann F, Tamayo-Lomas L, Trenado J, Úbeda A, Valdivia LJ, Vidal P, Bermejo J, Gonzalez J, Barbe F, Calfee CS, Artigas A, Torres A; CIBERESUCICOVID Project. Ceccato A, et al. Crit Care. 2024 Mar 21;28(1):91. doi: 10.1186/s13054-024-04876-5. Crit Care. 2024. PMID: 38515193 Free PMC article.
98 results